| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:07:47 -0700 |
| HMDB ID |
HMDB00032 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
7-Dehydrocholesterol |
| Description |
7-Dehydrocholesterol is a zoosterol (a sterol produced by animals rather than plants). It is a provitamin-D. The presence of this compound in skin enables humans to manufacture vitamin D3 from ultra-violet rays in the sun light, via an intermediate isomer provitamin D3. It is also found in breast milk. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (-)-7-dehydrocholesterol
- (3b)-Cholesta-5,7-dien-3-ol
- (3beta)-Cholesta-5,7-dien-3-ol
- 10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol
- 17-(1,5-Dimethylhexyl)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
- 5,7-Cholestadien-3-beta-ol
- 5,7-Cholestandien-3-ol
- 5,7-Cholestandien-3beta-ol
- 7,8-Dehydro-cholesterol
- 7,8-Didehydrocholesterol
- 7-Dehydro-cholesterol
- 7-Dehydrocholesterin
- 7-Dehydrocholesterol
- 7DHC
- Cholesta-5,7-dien-3 beta -ol
- Cholesta-5,7-dien-3-beta-ol
- Cholesta-5,7-dien-3-ol
- Cholesta-5,7-dien-3b-ol
- Cholesta-5,7-dien-3beta-ol
- Dehydrocholesterin
- Dehydrocholesterol
- Delta5,7-Cholestadien-3beta-ol
- Delta5,7-Cholesterol
- Delta7-Cholesterol
- Provitamin D3
- Provitamin-D3
|
| Chemical Formula |
C27H44O |
| Average Molecular Weight |
384.6377 |
| Monoisotopic Molecular Weight |
384.33921603 |
| IUPAC Name |
(1S,2R,5S,11R,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,9-dien-5-ol |
| Traditional IUPAC Name |
7-dehydrocholesterol |
| CAS Registry Number |
434-16-2 |
| SMILES |
[H][C@@]12CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC[C@@]1([H])C2=CC=C2C[C@@H](O)CC[C@]12C |
| InChI Identifier |
InChI=1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1 |
| InChI Key |
UCTLRSWJYQTBFZ-DDPQNLDTSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Steroids and Steroid Derivatives |
| Sub Class |
Cholesterols and Derivatives |
| Other Descriptors |
- Aliphatic Homopolycyclic Compounds
- Cholesterol and derivatives(Lipidmaps)
|
| Substituents |
- 3 Hydroxy Steroid
- Bicyclohexane
- Cyclic Alcohol
- Cyclohexane
- Secondary Alcohol
- Sesterterpene
|
| Direct Parent |
Cholesterols and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Fuel and energy storage
- Fuel or energy source
- Hormones, Membrane component
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
- Cytoplasm
- Extracellular
- Membrane
- Endoplasmic reticulum
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
150.5 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
1 mg/mL |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
- Cytoplasm
- Extracellular
- Membrane
- Endoplasmic reticulum
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
- Fibroblasts
- Testes
- Liver
- Brain
- Adrenal Gland
- Fetus
- Skin
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
5.0 +/- 2.2 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0 - 0.02 uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.029 (0.0068-0.051) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
369.0 (46.0 - 1220.0) uM |
Adult (>18 years old) |
Both |
Smith-Lemli-Opitz syndrome |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.3 +/- 0.2 (0.1 - 0.6) uM |
Infant (0-1 year old) |
Both |
Smith-Lemli-Opitz syndrome |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Smith-Lemli-Opitz syndrome |
- van Rooij A, Nijenhuis AA, Wijburg FA, Schutgens RB: Highly increased CSF concentrations of cholesterol precursors in Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 1997 Aug;20(4):578-80.
Pubmed: 9266395
- Johnson DW, ten Brink HJ, Jakobs C: A rapid screening procedure for cholesterol and dehydrocholesterol by electrospray ionization tandem mass spectrometry. J Lipid Res. 2001 Oct;42(10):1699-705.
Pubmed: 11590227
|
|
| Associated OMIM IDs |
- 270400
(Smith-Lemli-Opitz syndrome)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021882 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
388534  |
| KEGG Compound ID |
C01164  |
| BioCyc ID |
7-DEHYDRO-CHOLESTEROL  |
| BiGG ID |
36958  |
| Wikipedia Link |
7-Dehydrocholesterol  |
| NuGOwiki Link |
HMDB00032  |
| Metagene Link |
HMDB00032  |
| METLIN ID |
5101  |
| PubChem Compound |
439423  |
| PDB ID |
Not Available |
| ChEBI ID |
17759  |
| References |
| Synthesis Reference |
William G. Dauben, Jerome F. Eastham, and Robert A. Micheli A new method for the preparation of 7-dehydrocholesterol. Journal of the American Chemical Society (1951), 73 4496. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Lehmann B, Genehr T, Knuschke P, Pietzsch J, Meurer M: UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol. 2001 Nov;117(5):1179-85.
Pubmed: 11710930
- Muzzin KB, Harper LF: Smith-Lemli-Opitz syndrome: a review, case report and dental implications. Spec Care Dentist. 2003;23(1):22-7.
Pubmed: 12887150
- Paterson CR, Moody JP, Pennington CR: Skin content of 7-dehydrocholesterol in patients with malabsorption. Nutrition. 1997 Sep;13(9):771-3.
Pubmed: 9290088
- Jira PE, Wevers RA, de Jong J, Rubio-Gozalbo E, Janssen-Zijlstra FS, van Heyst AF, Sengers RC, Smeitink JA: Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome. J Lipid Res. 2000 Aug;41(8):1339-46.
Pubmed: 10946022
- Johnson DW, ten Brink HJ, Jakobs C: A rapid screening procedure for cholesterol and dehydrocholesterol by electrospray ionization tandem mass spectrometry. J Lipid Res. 2001 Oct;42(10):1699-705.
Pubmed: 11590227
- van Rooij A, Nijenhuis AA, Wijburg FA, Schutgens RB: Highly increased CSF concentrations of cholesterol precursors in Smith-Lemli-Opitz syndrome. J Inherit Metab Dis. 1997 Aug;20(4):578-80.
Pubmed: 9266395
- Andersson HC, Frentz J, Martinez JE, Tuck-Muller CM, Bellizaire J: Adrenal insufficiency in Smith-Lemli-Opitz syndrome. Am J Med Genet. 1999 Feb 19;82(5):382-4.
Pubmed: 10069708
- GarciaFuentes E, icioso Recio MV, del Castillo Acedo Del Olmo E, atas Jurado MM, Arana Aguera M, Lopez Lopez J: [Biochemical diagnosis of Smith-Lemli-Opitz syndrome in a patient with congenital adrenal hyperplasia] An Esp Pediatr. 2000 Nov;53(5):482-7.
Pubmed: 11141372
- Jezela-Stanek A, Malunowicz EM, Ciara E, Popowska E, Goryluk-Kozakiewicz B, Spodar K, Czerwiecka M, Jezuita J, Nowaczyk MJ, Krajewska-Walasek M: Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies. Clin Genet. 2006 Jan;69(1):77-85.
Pubmed: 16451140
- Moody JP, Humphries CA, Allan SM, Paterson CR: Determination of 7-dehydrocholesterol in human skin by high-performance liquid chromatography. J Chromatogr. 1990 Aug 24;530(1):19-27.
Pubmed: 2277111
|